85 related articles for article (PubMed ID: 24440748)
1. Regulatory feedback loop between T3 and microRNAs in renal cancer.
Boguslawska J; Piekielko-Witkowska A; Wojcicka A; Kedzierska H; Poplawski P; Nauman A
Mol Cell Endocrinol; 2014 Mar; 384(1-2):61-70. PubMed ID: 24440748
[TBL] [Abstract][Full Text] [Related]
2. Untranslated regions of thyroid hormone receptor beta 1 mRNA are impaired in human clear cell renal cell carcinoma.
Master A; Wójcicka A; Piekiełko-Witkowska A; Bogusławska J; Popławski P; Tański Z; Darras VM; Williams GR; Nauman A
Biochim Biophys Acta; 2010 Nov; 1802(11):995-1005. PubMed ID: 20691260
[TBL] [Abstract][Full Text] [Related]
3. MiR-224 targets the 3'UTR of type 1 5'-iodothyronine deiodinase possibly contributing to tissue hypothyroidism in renal cancer.
Boguslawska J; Wojcicka A; Piekielko-Witkowska A; Master A; Nauman A
PLoS One; 2011; 6(9):e24541. PubMed ID: 21912701
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma.
Yoshino H; Enokida H; Itesako T; Tatarano S; Kinoshita T; Fuse M; Kojima S; Nakagawa M; Seki N
J Hum Genet; 2013 Aug; 58(8):508-16. PubMed ID: 23635949
[TBL] [Abstract][Full Text] [Related]
6. miR-21 downregulated TCF21 to inhibit KISS1 in renal cancer.
Zhang H; Guo Y; Shang C; Song Y; Wu B
Urology; 2012 Dec; 80(6):1298-302.e1. PubMed ID: 23206776
[TBL] [Abstract][Full Text] [Related]
7. microRNA-107 functions as a candidate tumor suppressor gene in renal clear cell carcinoma involving multiple genes.
Song N; Ma X; Li H; Zhang Y; Wang X; Zhou P; Zhang X
Urol Oncol; 2015 May; 33(5):205.e1-11. PubMed ID: 25758424
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of thyroid hormone receptor beta in renal cancer.
Wojcicka A; Piekielko-Witkowska A; Kedzierska H; Rybicka B; Poplawski P; Boguslawska J; Master A; Nauman A
PLoS One; 2014; 9(5):e97624. PubMed ID: 24849932
[TBL] [Abstract][Full Text] [Related]
9. YY1-C/EBPα-miR34a regulatory circuitry is involved in renal cell carcinoma progression.
Weng W; Wang M; Xie S; Long Y; Li F; Sun F; Yu Y; Li Z
Oncol Rep; 2014 Apr; 31(4):1921-7. PubMed ID: 24481728
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
Nakada C; Matsuura K; Tsukamoto Y; Tanigawa M; Yoshimoto T; Narimatsu T; Nguyen LT; Hijiya N; Uchida T; Sato F; Mimata H; Seto M; Moriyama M
J Pathol; 2008 Dec; 216(4):418-27. PubMed ID: 18925646
[TBL] [Abstract][Full Text] [Related]
11. Thyroid hormone receptor represses miR-17 expression to enhance tumor metastasis in human hepatoma cells.
Lin YH; Liao CJ; Huang YH; Wu MH; Chi HC; Wu SM; Chen CY; Tseng YH; Tsai CY; Chung IH; Wu TI; Tsai MM; Lin CD; Lin KH
Oncogene; 2013 Sep; 32(38):4509-18. PubMed ID: 23912452
[TBL] [Abstract][Full Text] [Related]
12. Triiodothyronine regulates cell growth and survival in renal cell cancer.
Czarnecka AM; Matak D; Szymanski L; Czarnecka KH; Lewicki S; Zdanowski R; Brzezianska-Lasota E; Szczylik C
Int J Oncol; 2016 Oct; 49(4):1666-78. PubMed ID: 27632932
[TBL] [Abstract][Full Text] [Related]
13. Regulation of fibronectin by thyroid hormone receptors.
Lin KH; Chen CY; Chen SL; Yen CC; Huang YH; Shih CH; Shen JJ; Yang RC; Wang CS
J Mol Endocrinol; 2004 Oct; 33(2):445-58. PubMed ID: 15525600
[TBL] [Abstract][Full Text] [Related]
14. 3,5-di-iodothyronine stimulates tilapia growth through an alternate isoform of thyroid hormone receptor β1.
Navarrete-Ramírez P; Luna M; Valverde-R C; Orozco A
J Mol Endocrinol; 2014 Feb; 52(1):1-9. PubMed ID: 24031088
[TBL] [Abstract][Full Text] [Related]
15. miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
White NM; Bao TT; Grigull J; Youssef YM; Girgis A; Diamandis M; Fatoohi E; Metias M; Honey RJ; Stewart R; Pace KT; Bjarnason GA; Yousef GM
J Urol; 2011 Sep; 186(3):1077-83. PubMed ID: 21784468
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of microRNA expression in renal cell carcinoma.
Schiffgen M; Schmidt DH; von Rücker A; Müller SC; Ellinger J
Biochem Biophys Res Commun; 2013 Jun; 436(1):79-84. PubMed ID: 23707942
[TBL] [Abstract][Full Text] [Related]
17. The entire miR-200 seed family is strongly deregulated in clear cell renal cell cancer compared to the proximal tubular epithelial cells of the kidney.
Duns G; van den Berg A; van Dijk MC; van Duivenbode I; Giezen C; Kluiver J; van Goor H; Hofstra RM; van den Berg E; Kok K
Genes Chromosomes Cancer; 2013 Feb; 52(2):165-73. PubMed ID: 23074016
[TBL] [Abstract][Full Text] [Related]
18. microRNA-125a-3p reduces cell proliferation and migration by targeting Fyn.
Ninio-Many L; Grossman H; Shomron N; Chuderland D; Shalgi R
J Cell Sci; 2013 Jul; 126(Pt 13):2867-76. PubMed ID: 23606749
[TBL] [Abstract][Full Text] [Related]
19. Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma.
Zhai Q; Zhou L; Zhao C; Wan J; Yu Z; Guo X; Qin J; Chen J; Lu R
Biochem Biophys Res Commun; 2012 Mar; 419(4):621-6. PubMed ID: 22369946
[TBL] [Abstract][Full Text] [Related]
20. T3 enhances thyroid cancer cell proliferation through TRβ1/Oct-1-mediated cyclin D1 activation.
Perri A; Catalano S; Bonofiglio D; Vizza D; Rovito D; Qi H; Aquila S; Panza S; Rizza P; Lanzino M; Andò S
Mol Cell Endocrinol; 2014 Jan; 382(1):205-217. PubMed ID: 24121026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
